Publications by authors named "Chung-Chieh Hu"

Purpose: The early integration of palliative care for terminally ill cancer patients improves quality of life. We have developed a new nurse-led consultation model for use in a palliative care consultation service (PCCS) to initiate early palliative care for cancer patients.

Methods: In this 11-year observational study, data were collected from the Hospice-Palliative Clinical Database (HPCD) of Taichung Veterans General Hospital (TCVGH).

View Article and Find Full Text PDF

Background: Terminally ill patients often experience exacerbations of diseases that render mainstream medicine ineffective in relieving symptoms, prompting attempts at complementary and alternative medicine (CAM). This study collected data from terminally ill patients and their relatives to determine differences between CAM use, behavioral patterns, and perceptions of health information about CAM.

Methods: A cross-sectional design using a self-administered questionnaire was adopted.

View Article and Find Full Text PDF
Article Synopsis
  • Early integration of palliative care for terminally ill non-cancer patients enhances quality of life, yet research on its application is limited.
  • A 9-year study analyzed data from Taichung Veterans General Hospital focusing on non-cancer patients receiving Palliative Care Consultation Service (PCCS), highlighting trends in diagnoses, patient outcomes, and Do Not Resuscitate (DNR) declarations.
  • Results showed significant differences in demographics, disease awareness, and outcomes linked to various diagnoses, with organic brain disease and chronic kidney disease being the most common among patients; moreover, a high percentage consistently opted for DNR consent early in the study.
  • The findings advocate for the importance of integrating PCCS into standard care for non-cancer patients to improve
View Article and Find Full Text PDF
Article Synopsis
  • Early integration of palliative care consultation services (PCCS) enhances the quality of life for both terminally ill cancer and non-cancer patients, though data comparing the two groups is limited.
  • A 9-year observational study at Taichung Veterans General Hospital tracked the PCCS outcomes for 5223 cancer patients and 536 non-cancer patients from 2011 to 2019, revealing that cancer patients had a longer average duration of PCCS (21.4 days) compared to non-cancer patients (18.4 days).
  • Findings indicated that while cancer patients were less likely to declare do-not-resuscitate (DNR) orders (82% vs. 98%) and had more transfers to specialized care, those
View Article and Find Full Text PDF

Background: Medical staff may have difficulties in using conventional medicine to manage symptoms among terminally ill patients, including adverse effects of the treatment. Traditional Chinese medicine (TCM) is regarded as a complementary or alternative medicine, and has been increasingly used in the field of palliative medicine in recent years. This study aimed to investigate the experiences of and attitudes toward using TCM among palliative care professionals, and to provide preliminary information about its use in palliative care.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the link between do-not-resuscitate (DNR) orders and the use of strong opioid painkillers in terminal cancer patients in Taiwan.
  • It reviews data from patients who had a DNR order between 2008 and 2016, finding that a significant portion received higher doses of opioids after signing the DNR.
  • The results suggest that DNR status may affect doctors' choices in prescribing these pain medications, but further research is needed to understand the factors behind those decisions.
View Article and Find Full Text PDF

Background: Some patients who receive hospice home care still end up dying in hospital. The significance of the variables possibly affecting the place of death in patients with terminal cancer who received hospice home care was examined.

Methods: Retrospective study.

View Article and Find Full Text PDF

To evaluate the effect of alendronate combined with hormone replacement therapy (HRT) on postmenopausal osteoporotic Chinese women living in Taiwan, we treated 151 women (age range, 47-70 years; mean, 61 years) with conjugated equine estrogen (0.625 mg), medroxyprogesterone 5 mg, and elemental calcium 500 mg daily with either alendronate 10 mg (n = 79) or placebo (n = 72), and measured their bone mineral density (BMD) at the lumbar spine and hip every 6 months for 3 years. Urine N-telopeptide of type I collagen corrected by concentration of urine creatinine (NTx/Cr) and serum osteocalcin (OC) concentration was also measured at weeks 2, 4, and every 3 months from month 3 for 2 years.

View Article and Find Full Text PDF